AlloVir

AlloVir

Biotechnology Research Waltham, Massachusetts, United States 17 employees
Employees
17
Contacts
4
Emails
4
Phones
1

AlloVir Overview

Headquarters
Waltham, Massachusetts, United States
Phone Number
Available in AeroLeads
Website
allovir.com
Industry
Biotechnology Research
Employees
17
Funding
75.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About AlloVir

AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

AlloVir Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

AlloVir Org Chart

Sample employees and titles
Name Title Contact
Siva Sivaji G, Phd Head of Quality Control Operations
Email
Jeffrey Bornstein Managing Partner at Generation Capital
Email
Wesley Chen Senior Manager at Allovir, Inc.
Email
Jody Murphy Global Payroll and Benefits Manager
Email Phone

Employees by Management Level

Manager 3 profiles
Individual contributor 3 profiles
VP / Head 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 0

AlloVir Tech Stack

Data / AI 1 profile

Compare Similar Companies to AlloVir